Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

por Lenzo, Nat P., Meyrick, Danielle, Turner, J. Harvey
Publicado 2018

Renal outcomes of radioligand therapy: experience of (177)lutetium—prostate-specific membrane antigen ligand therapy in metastatic castrate-resistant prostate cancer

por Gallyamov, Marat, Meyrick, Danielle, Barley, Jerome, Lenzo, Nat
Publicado 2019

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer

por Asokendaran, Marcus Edward, Meyrick, Danielle P., Skelly, Laura A., Lenzo, Nat P., Henderson, Andrew
Publicado 2019

Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen i...

por Kesavan, Murali, Meyrick, Danielle, Gallyamov, Marat, Turner, J. Harvey, Yeo, Sharon, Cardaci, Giuseppe, Lenzo, Nat P.
Publicado 2021

(177)Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer

por von Eyben, Finn Edler, Singh, Aviral, Zhang, Jingjing, Nipsch, Karin, Meyrick, Danielle, Lenzo, Nat, Kairemo, Kalevi, Joensuu, Timo, Virgolini, Irene, Soydal, Cigdem, Kulkarni, Harshad R., Baum, Richard Paul
Publicado 2019